111828-85-4

Basic information

• Product Name: 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-benzyl-L-myo-inositol
• Synonyms: 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-benzyl-L-myo-inositol
• CAS NO: 111828-85-4
• Molecular Weight: 610.745
• Mol File: 111828-85-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-benzyl-L-myo-inositol(CAS DataBase Reference)
• NIST Chemistry Reference: 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-benzyl-L-myo-inositol(111828-85-4)
• EPA Substance Registry System: 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-benzyl-L-myo-inositol(111828-85-4)

Safety Data

• Hazardous Substances Data: 111828-85-4(Hazardous Substances Data)

Upstream product

• 34361-60-9 1,2:4,5-dicyclohexylidene-myo-inositol 
• 39637-74-6 (1S)-(-)-camphanic chloride 
• 23393-20-6 (+/-)-3-O-benzyl-1,2:4,5-di-O,O-cyclohexylidene-myo-inositol 

Downstream Products

• 34361-60-9 D-1,2:4,5-di-O-cyclohexylidene-myo-inositol 
• 132891-78-2 1,2;4,5-Di-O-cyclohexylidene-3-O-dibenzylphosphoryl-L-myo-inositol 
• 132891-78-2 1,2;4,5-Di-O-cyclohexylidene-3-O-dibenzylphosphoryl-L-chiro-inositol 
• 34361-60-9 1,2;4,5-Di-O-cyclohexylidene-L-chiro-inositol 
• 129094-41-3 C₄₂H₅₃O₁₂P 
• 129094-41-3 6-O-Camphanoyl-1,2;4,5-di-O-cyclohexylidene-3-O-dibenzylphosphoryl-L-myo-inositol 
• 111828-83-2 (+)-1-⁽³⁾-benzyl-2,3:5,6-(1,2:4,5)-dicyclohexylidene-myo-inositol 4-⁽⁶⁾-diphenylphosphate 
• 111901-84-9 D-myo-inositol 6-monophosphate 
• 23393-20-6 1D-3-O-benzyl-1,2:4,5-di-O-cyclohexylidene-myo-inositol 

Relevant articles and documents

THE TOTAL SYNTHESIS OF myo-INOSITOL POLYPHOSPHATES

Total synthesis of the individual enentiomers of myo-inositol 4-phosphate (15), myo-inositol 1,4-biphosphate (2) and myo-inositol 1,4,5-triphosphate (1), together with syntheses of racemic myo-inositol 1,3,4-triphosphate (4) and myo-inositol 2,4,5-triphos

Synthesis of myo-Inositol 1-Phosphate and 4-Phosphate, and of their Individual Enantiomers

New methodology is described which allows the synthesis of myo-inositol 1-phosphate completely free of contamination by the 2-isomer, and novel resolution procedures have been developed for the preparation of the enantiomers of myo-inositol 1- and 4-phosp